FDA warns 3 U.S. CBD sellers over ‘egregious’ cancer claims

The U.S Food & Drug Administration (FDA) and the Federal Trade Commission jointly issued warning letters to three American companies for unsubstantiated claims regarding CBD. The claims are carried in online platforms operated by the companies as well as social media, FDA said.